EMEA-001475-PIP03-17-M02

Key facts

Active substance
Maralixibat chloride (LUM001)
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0200/2020
PIP number
EMEA-001475-PIP03-17-M02
Pharmaceutical form(s)
Oral solution
Condition(s) / indication(s)
Treatment of Progressive Familial Intrahepatic Cholestasis
Route(s) of administration
Oral use
Contact for public enquiries
Mirum Pharmaceuticals

E-mail: medinfo@mirumpharma.com
Tel.  +1 6506674085

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating